Skip to main content
HOUSE 5547118th CongressReferred to the Subcommittee on Health.

Maintaining Investments in New Innovation Act

Last Action
12/17/2024

Actions

  • 2024-12-17Referred to the Subcommittee on Health.
  • 2023-09-22Referred to the Subcommittee on Health.
  • 2023-09-18Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2023-09-18Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2023-09-18Introduced in House
  • 2023-09-18Introduced in House

CRS Summary

As of 2023-09-18 (00)

Maintaining Investments in New Innovation Act

This bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.)

Cosponsors (20)

  • John Joyce (R-PA)
  • Donald Davis (D-NC)
  • Scott Peters (D-CA)
  • Dan Crenshaw (R-TX)
  • Larry Bucshon (R-IN)
  • Richard Hudson (R-NC)
  • A. Ferguson (R-GA)
  • Rick Allen (R-GA)
  • Diana Harshbarger (R-TN)
  • Adrian Smith (R-NE)
  • Daniel Meuser (R-PA)
  • Blake Moore (R-UT)
  • Mariannette Miller-Meeks (R-IA)
  • Nicole Malliotakis (R-NY)
  • Vern Buchanan (R-FL)
  • Mike Carey (R-OH)
  • Beth Van Duyne (R-TX)
  • Sheila Cherfilus-McCormick (D-FL)
  • Mike Kelly (R-PA)
  • Lloyd Smucker (R-PA)

Subjects

  • Genetics
  • Medicare
  • Prescription drugs
Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.